A Six-Week randomized, parallel design study to compare the effects of philips sonicare 9900 prestige versus an Oscillating-Rotating power toothbrush on plaque and gum health
NCT ID NCT07813546
First seen Sep 10, 2026 ยท Last updated Sep 10, 2026
Summary
The goal of this clinical trial is to learn if powered toothbrushing with a side-to-side motion is more effective than powered toothbrushing with oscillating-rotation motion in removing dental plaque. It will also learn about the safety of power toothbrushing with both products. The main questions the study aims to answer are: Does side-to-side power toothbrushing remove more dental plaque than oscillating-rotation toothbrushing? Does side-to-side power toothbrushing reduce symptoms of gingivitis better than oscillating-rotation toothbrushing? Participants will: Brush their teeth twice a day with either a side-to-side or oscillating-rotation power toothbrush Visit the clinic twice during the study: once at baseline and six weeks after the study starts. Keep a diary of when they brushed their teeth
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
295 people
The number who actually took part.
- Started
-
May 2021
- Finished
-
Jul 2021
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 59 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Be in general good health * Be willing and physically able to carry out all study procedures and be available at all times required for participation * Be able to fully understand and comply with the written and verbal instructions provided * Provide written informed consent * Be willing to attend all study visits * Agree to return study materials at the required visit(s) * Between the ages of 18-59 years * Be a non-smoker * Have a minimum of 20 'scorable' teeth (excluding 3rd molars) * Have an average plaque score of \>1.8 per Modified Plaque Index scoring with 3-6 hours of plaque accumulation * Have a gingival bleeding score of \>1 on a minimum of 50 gingival sites per Gingival Bleeding Index * Be a regular manual toothbrush user Exclusion Criteria: * Are pregnant or nursing per subject report * A medical or dental condition that would be unduly affected by participation in this study, per Investigator discretion * A medical condition requiring antibiotic pre-medication prior to dental appointments * Diagnosis of xerostomia * Oral or extra oral piercing that interferes with the ability to perform study procedures and/or clinical assessments in the mouth * Currently undergoing or requiring dental/periodontal treatment, or having had periodontal treatment in the six months preceding the study, where the subject's study participation could present an undue safety risk or obscure the evaluation of study endpoints, per Investigator/Examiner discretion * Oral surgery within the last 2 months * Currently using professionally dispensed bleaching products * A known allergy or sensitivity to products planned for use in this study * Unwilling to abstain from all other oral hygiene products other than those prescribed for the duration of the study * Participated in an oral care study within the previous 60 days * Employee or a relative of an employee of the Site clinical research department, dental school, or a dental products manufacturing, research or marketing firm * Dental student or dental professional * A cardiac pacemaker or implanted cardiac defibrillator * Insulin-Dependent Diabetes * Immunocompromised or Immune-impaired/suppressed. * Current use of antibiotic medications or use within 4 weeks of enrollment * Current use of prescription-dose anti-inflammatory medications or anticoagulants; (including aspirin \> 81 mg daily) * Presence of advanced periodontal disease or excessive gingival recession, per Investigator/Examiner discretion * Heavy deposits of calculus, either supragingival and/or subgingival, per Investigator/Examiner discretion * Extensive crown or bridge work and/or rampant decay, per Investigator/Examiner discretion * Presence of orthodontic bands, wires or brackets * A professional prophylaxis within 4 weeks of the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gingiviits are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Salus Research, Inc.
Fort Wayne, Indiana, 46825, United States